E G g~T G i n t s of Pediottics, Medico1 U n i v e~s i t y o f Luebeck onrl U n i v e~s i t y o f Koeln, G e~m o n y EFFECT O F GROWTH HORMONE (GH) TREATMENT ON BONE METABOLISM IN ULLRICH-TURNER-SYNDROME (UTS)
Background ond Methods. The cause of decceosed bone m i n e~o l i r o t i o n in UTS and the e f f e c t of diffetent doses of GH on bone tuLnovel a t e unknown. W e thezefole meosvled totol (AP) and bone (BAP) alkaline phosphotase ond osteocalcin (Oc) a s rnalkels of osteohlastic bone folmotion and l h e hydloxyp t o l i n e -c t e o t i n i n e~t o t i o (OH-P/Cz) in fasting rnoining "tine os o n index o f osteoclostic lhone degiudollon, us well us IGF-I as a n index of the e f f e c t of exogenous GH on its teceptot. P a t i e n t s a n d Study Protocol. 80 u n t~e o t c d p~e p u b e l to1 gills with UTS (bone a g e 3 -I l y l ) w e l e studied p l i o~ t o and most of them aftes o 21-33 monthsthelapy with 3 diffelent doses of GH (Hurnot~ope, Lilly), given subcutoneously: 2U/sqrn/doy (UTS-ZU, n = 27), 3 U/sqm/doy (UTS-3U, n = 24) and 4 U/ sqm/doy (UTS-4U, n = 19). The lesulls w e~c compaled to 8 lpatients wit11 g~o w t h holmone deficiency (GHD) p l i o~ and during GH therapy with 2 U/ sqm/doy and 25 healthy age-matched contlols (bosol levels of bone metobol.)
Results. IGF-I was notmol in UTS-gloups and GHD. AP, BAP ond O c weLe d e c~e a s e d p l i o~ t o GH tceotrnent ond showed o lowe, lesponse tho" in the patients with GHD (leceiving only 2 U), even o t o dose o f 4 U in potients with UTS. In conllast, OHP/CI was nolrnol b c f o l e t t e o t m e n t and showed a dose-dependent inctcose in the 3 UTS-gtoul,s.
Conclusions. O U I study indicates t h a t childlen wit17 UTS hove ,educed osteoblostic bone f o~m o t i o n but u n i m p o i~e d osteoclostic bone d e g~a d o t i o n and t h a t this imbolonce moy wolsen d u~i n g t l e o t m e n t with high doses o f GH. The contribution 01 GH and sex steroids to attainment of oeak bone mass are not clear and rcqunc londltdd~nal sludles. \Vc arc cxanllnlng 111: 1nlcra.t.ons ktuecrl lcsto,lrrorlc UJ (ill on BhlD usu~w the GH Jtficlzn! and GtI h~1f1acr.t 1. 1 mhlelr (Leuli suaul). In the l~rst oan of study, 1ort;male GH deficient rats were included with half the rats castraied at age 4 w k b and hall remained as controls. All rats received identical diet and housing. BMD 01 total body, lemur and lumbar spine (Ll-LA) were measured from early adulthmd a1 age 12 and 36 weeks, using Dual Energy X-ray Absorpuometry (DEXA. LUNAR) equipped with special soltware for small animals.
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This DEXA soltware was validated for small animals prior to the study. There was suong agreement between bone mineral content and ash weight lor total body (?=0.90) and femur (h0.83) in 17 rats with weight ranging from 146 to 212 grams. At age 12 weeks, there was no difference in total body, lemur and LI-L4 BMD between Iwo groups. However at 36 weeks. the castrated rats had significantly lower L1-L4 BMD compared to the c o n~o l s (data not shown). From age 12 to 36 weeks. rats 01 both groups had signilicant increase in total body and lemur BMD (lelt). The castrated group had no increase in L1-L4 BMD, wllicll is signilicanlly dillerent lrom the control rats.
We conclude Ilia1 leslostcrone, even in the presence 01 GH deficiency, is critical for maintaining BMD 01 lumbar spine, which is prcdominanlly Udbecular bonc. The impact 01 GH deficiency on BMD will be examined in the second part of study with GH dcficienl and sulficient models. H.WogelJ and t h e Germany r i c k e t s s t u d y g r o u p C h i l d r e n ' s h o s p l t e l s of ~e r l i n -~i c h t e n b e r~l , l l a l l e 2 and .lena3. Germany
466
The e f f e c l s o t p r o p h y l a c t l c a d m~n l s t r a t i o n of 400 IU c o n t a l n l n g v l t a m l n D3 t a b l e t s were t e s t e d I" 2707 newborn t o 15-sonth-old i n f a n t s . Only V l t a n l n D f r e e formula 011k5 Were used i n formula-ted ~n f a n t s . V l t a a l n U3 prophylaxis was s t a r t e d xn t h e 2nd weep. of l l f e . 57 o u t of 8 9 ( 6 4 % ! ) one-weeko l d n e r b o r n s had 2 5 OH-D serum c o n c . below 2 0 ' nmol/l ( r a n g e 20-130 nmo1/1.
method Aksnes e t a l . C l l n .
Chem. 104. 1980:135.147) .
Acta
Under 400 IU o f vit.D3/day 2 5 OH-D i n c r e a s e d from 22.6 ? 13.8 t o 8 j . l t 36.1 n c c l / l from t h e znd week t o t h e 3rd month ( n = 163. p < 0.0001) and t o 92.9 + 36.6 n a o l / l between 4-6 months (n = 182. p > 0.0001). E l e v a t e d 2 5 OH-D conc.
(;I30 n m o l / l ) were found i n 35/54> (10.1::) In t h e f l r s t h a l f y e a r and 4/14? (2.6 % I ~n t h e second one. E l e v a t e d calcium serum conc. (: 2.8 m a o l / l ) were observed l n 28 of 439. l n f a n t s (6.4 : : I In t h e f l r s t 6 monthe. Anorq. plnospllate conc. above > 2.4 mmol/l were measured ~n 143 of 616 (23.2 % ) . (Ca v a l u e s d. 2.0 mmol/l = 2).One of 2707 i n f a n t s had rickets. S l l q h t l y e l e v a t e d a l k . phosoh. c u n c . ( > 12.5 n n o l / l . s were found ~n 8 7 of 676 i n f a n t s (12.9 : : I I" spite of normal Ca. P and 2 5 OH-D conc. Csn&:
Daily a p p l l c . of 400 I € Vlt.D3 day l e a d s t o i n c r e a s e d 25 Oli-0 and c a l c . conc. ~n t h e f l r s t 6 e o n t h s of l i t e . 300 IE " i t . U;/day a r e recomn,ended a s p r o p h y l a c t l c d o s e f o r t h e f l r s t and 400 lE/day f o r t h e second h a l f y e a r of l l f e .
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UL'IRI\SOWNU v m a a n IN L4, in 6 patients' with ~~1 -2 1 -h~d r o x~l a s e deficiency who had been exposed to age-discordant levels of adrenal hormones. 3/6 patients had been treated since infancy with low doses of glucocorticoids. Children (mean age 7.8 + 4 y) had advanced height age and bone ages ( 9 . 0 2 3.4y and 1 0 . 3 In practical pediatric endacrinolo~ assessment of currcnt height vclocily (HV) plays an important role lor diagnosis and trcatmenr 01 growth disordcrs. However, lo date, there is no quick and simplc mcthod to dctcrmine HV. Urinary excretion 01 (ialaclosylhydroxylysinc (GHLy), a marker ufoslcoclast actiwly, h.1~ bccn shown lo closely rcflcct the activity of bonc metabolism in adults. In this study we tested the hyporhesis that GHLy can also be uscd lo cvaluate skeletal growth in childrcn. GH1.y was measured in Wh-urincs 01 74 hcdlthy chlldrcn, 21 girls with Turner's syndrome ITU) and 15 children with erowih hormonc deficiencv (GHD). HV was calculated from . , ,~ . two measurements of body height 6 to 12 months apart. Whcn related to body weight, thc ?Ah excretion of GHLy showed a highly siguilicant correlalion to HV in normal childrcn (r-0.75, pc0.001) and GHD (r=;.6q, p=0.004) but no1 in TU (p>0.05). Data for weight-adjusted daily excretion 01 GHLy wcre lranslormcd Lo standard deviation scorci (SDS) to allow for comparison in dillerent agc groups. Thc mean SDS 01 both GHD and TU wcre signilicanlly below zcra ( -1 31 and -1.83 rcrpeaively; p<O.OS). Nonc of thc valuea in these two disordcrs was above the mean for healthy childrcn of the same age. Thus, GHLy might be a useful indicator of HV for the evaluation of growth disorders. Furlhcr studies arc needed lo lest if GHLy cxcrcuon can be uscd to prcdtct thc changes of Ss 1 HV during growth-promoting therapies.
